- Home
- LI vs BAX Comparison
LI vs BAX Comparison
Compare LI & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LI | BAX |
|---|---|---|
| Founded | 2015 | 1931 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 13.9B |
| IPO Year | 2019 | 1994 |
Fundamental Metrics
Financial Performance| Metric | LI | BAX |
|---|---|---|
| Price | $12.04 | $25.60 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 10 | 9 |
| Target Price | $19.66 | ★ $21.00 |
| AVG Volume (30 Days) | 2.4M | ★ 5.6M |
| Earning Date | 05-28-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.24% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.21 |
| Revenue | N/A | ★ $11,244,000,000.00 |
| Revenue This Year | $18.98 | $1.96 |
| Revenue Next Year | $22.72 | $2.22 |
| P/E Ratio | ★ $29.50 | $122.43 |
| Revenue Growth | N/A | ★ 5.72 |
| 52 Week Low | $11.65 | $15.73 |
| 52 Week High | $26.94 | $30.00 |
Technical Indicators
Market Signals| Indicator | LI | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 43.31 | 47.19 |
| Support Level | $12.09 | $18.31 |
| Resistance Level | $12.39 | $30.00 |
| Average True Range (ATR) | 0.28 | 0.69 |
| MACD | -0.04 | -0.29 |
| Stochastic Oscillator | 26.37 | 16.15 |
Price Performance
Historical ComparisonAbout LI Li Auto Inc.
Li Auto is one of China's leading new energy vehicle manufacturers. Founded in 2015, the company designs, develops, manufactures, and sells premium smart NEVs with a particular focus on family size premium SUVs and MPVs. Li Auto started volume production of its first model—the Li One, an SUV that is a premium plug-in electric vehicle- in November 2019. Besides PHEVs, its product portfolio now extends to EVs that are fully battery-powered, reaching a wide audience. It has sold over 400,000 NEVs in 2025, accounting for about 3% of China's passenger NEV market.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.